Pavel Rodiukov Email & Phone Number

Moscow, Russian Federation

Bash Today is a leading Russian marketplace for creative spaces hourly rental and public events organization. Whether a private party, business event or a master class is on agenda, Bash Today is the best place to choose venue and make associated arrangements for your event (catering, music, etc).

Trowbridge, England

Binx provides a first of its kind, comprehensive digital program that includes evidence-based sexually transmitted infection (STI) testing, counseling, treatment, and follow up in order to increase screening and reduce infections.

San Diego, California, United States

Moscow, Moscow, Russia

Moscow, Moscow, Russia

RMI LLC is the largest Russian VC fund exclusively specialized in the area of Life Sciences, having approximately $380M in committed capital. RMI activities dedicated to achievement of two principal objectives: building a lucrative and well diversified portfolio of foreign investment into startups that develops state-of-the-art technologies for medicine and healthcare and establishment of the Russian pharmaceutical company NovaMedica with product portfolio based on technology transfer from foreign investments by RMI and in-licensing opportunities from other healthcare companies.

Greater San Diego Area

OcuNexus Therapeutics is a development stage biopharmaceutical company with novel, proven gap junction channel modulation technologies targeting unmet clinical needs in ophthalmology.

Luxembourg

Mitotechw S.A. is a Luxembourg company that was formed for the purpose of the international development of intellectual property of "The Skulachev Ions" project and its further commercialization. Mitotech S.A. accumulates and maintains intellectual property associated with the Skulachev Ions project for jurisdictions outside Russia and CIS countries and conducts clinical trials in the US.

Moscow, Russia

Mitotech LLC is an innovative biopharmaceutical company formed in 2010 for management of "The Skulachev Ions" project, which objective is to enter the market with several products for treatment of spectrum of age-related diseases. Products are based on a fundamentally breakthrough mechanism of action that works at a sub-cellular level of mitochondria: by restoring of optimal level of reactive oxygen species for the cellular recovery from oxygenation stress, it was proven possible in various models to cure the whole organism for a number of age-related diseases. In 2012 the company successfully registered its' first product in Russia – Visomitin eye drops for relief from the "dry eye" inflammatory syndrome and entered the Russian Rx-class pharmaceuticals market. Currently the company conducts clinical trials for more indications and markets existing product for treatment of "dry eye".

Modiin, Israel

OCON Healthcare develops, manufactures and commercialises innovative women’s health products based on IUB™, its proprietary intrauterine platform. The platform, made of a super-elastic alloy Nitinol, is an ideal carrier for hormone-free contraception and intrauterine drugs.

Moscow, Russia

Trackpore Technology is a leading firm that develops, produces and markets medical equipment and disposables for afferent therapy of misc. diseases related to blood and cardiovascular system. In 2009 Trackpore Technology started the establishment of an art-class new manufacturing facility "Beta" for production of next-generation technologies in afferent therapy focused on cascade blood plasma filtration and other hi-tech blood treatment techniques, as well as to enter the donor market of blood plasma. "Beta" is also proposed to become capable of mass production of the hi-tech commodity – track-etched membrane with pore sizes ranging from 70 nm to 2 mkm for misc. applications where exists a strong demand for precise and penny-price filtration (ultrafiltration).

Greater Atlanta Area

Celtaxsys is a clinical-stage pharmaceutical development company focused on advancing novel foundational therapies to treat inflammation in rare, orphan designated diseases, with flagship drug candidate aimed at preserving lung function in cystic fibrosis.

Moscow, Russian Federation

HemaCore is a medical devices startup that develops innovative equipment and methods for hematology. HemaCore was founded in 2010 by a group of scientist who invented and patented the Thrombodynamics, a new reliable method for monitoring and prognosis of such blood coagulation disorders as thrombosis, the major cause of heart attacks and strokes, and bleeding (hemophilia).

Moscow, Russian Federation

Moscow, Russian Federation

Moscow, Russian Federation

Sertificates Of The 1.0 And 5.0 Series

Master Of Science (Ms), Business Administration And Management, General